ChemicalBook > CAS DataBase List > Deruxtecan

Deruxtecan

Product Name
Deruxtecan
CAS No.
1599440-13-7
Chemical Name
Deruxtecan
Synonyms
Deruxtecan;MC-GGFG-Exetecan;Deruxtecan analog;Deruxtecan(DX-8951);Ibandronate Impurity 32;MC-GGFG-Exetecan Deruxtecan analog;Drug-Linker Conjugates for ADC,Inhibitor,inhibit,Deruxtecan;Glycinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]glycylglycyl-L-phenylalanyl-N-[[2-[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl]amino]-2-oxoethoxy]methyl]-;N-[(S)-10-Benzyl-1-[[(1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-1,2,3,9,10,12,13,15-octahydrobenzo[de]pyrano[3’,4’:6,7]indolizino[1,2-b]quinolin-1-yl]amino]-1,6,9,12,15-pentaoxo-3-oxa-5,8,11,14-tetraazahexadecan-16-yl]-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamide;N-((S)-10-Benzyl-1-(((1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl)amino)-1,6,9,12,15-pentaoxo-3-oxa-5,8,11,14-tetraazahexadecan-16-yl)-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamide
CBNumber
CB24796642
Molecular Formula
C52H56FN9O13
Formula Weight
1034.05
MOL File
1599440-13-7.mol
More
Less

Deruxtecan Property

Boiling point:
1491.1±65.0 °C(Predicted)
Density 
1.48±0.1 g/cm3(Predicted)
solubility 
DMSO:67.5(Max Conc. mg/mL);65.28(Max Conc. mM)
pka
11.18±0.40(Predicted)
InChI
InChI=1S/C52H56FN9O13/c1-3-52(73)33-19-38-48-31(23-62(38)49(70)32(33)25-75-51(52)72)47-35(14-13-30-28(2)34(53)20-36(59-48)46(30)47)57-43(67)26-74-27-60(24-39(54)63)50(71)37(18-29-10-6-4-7-11-29)58-42(66)22-56-41(65)21-55-40(64)12-8-5-9-17-61-44(68)15-16-45(61)69/h4,6-7,10-11,15-16,19-20,35,37,73H,3,5,8-9,12-14,17-18,21-27H2,1-2H3,(H2,54,63)(H,55,64)(H,56,65)(H,57,67)(H,58,66)/t35-,37-,52-/m0/s1
InChIKey
XSLGWYQNBQGZTG-MCZRLCSDSA-N
SMILES
C(N)(=O)CN(C(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)CCCCCN1C(=O)C=CC1=O)COCC(N[C@@H]1C2C3C(N=C4C5N(C(=O)C6COC(=O)[C@@](CC)(O)C=6C=5)CC4=2)=CC(F)=C(C)C=3CC1)=O
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

ChemScene
Product number
CS-0045125
Product name
Deruxtecan
Purity
99.43%
Packaging
1mg
Price
$750
Updated
2021/12/16
ChemScene
Product number
CS-0045125
Product name
Deruxtecan
Purity
99.43%
Packaging
5mg
Price
$1500
Updated
2021/12/16
ChemScene
Product number
CS-0045125
Product name
Deruxtecan
Purity
99.43%
Packaging
10mg
Price
$1950
Updated
2021/12/16
More
Less

Deruxtecan Chemical Properties,Usage,Production

Uses

Deruxtecan is an ADC drug-linker conjugate composed of a derivative of DX-8951 (DXd) and a maleimide-GGFG peptide linker, used for synthesizing DS-8201 and U3-1402.

Indications

By Deruxtecan Preparation Trastuzumab deruxtecan drug is approved by the FDA for the treatment of patients with any HER2-positive advanced solid tumour (e.g., breast, gastric, and GOJ adenocarcinomas) and only after the patient has previously received other advanced treatments.

Mechanism of action

Deruxtecan is attached to the antibody by a peptide linker. After trastuzumab deruxtecan binds to HER2 found on malignant cells, it is internalized and linker cleavage occurs through the actions of lysosomal enzymes. After it is released through cleavage, DXd causes targeted DNA damage and apoptosis in cancer cells, due to the ability to cross cell membranes.

Side effects

The most common side effects of Deruxtecan (Trastuzumab deruxtecan) include: nausea, vomiting, diarrhoea, fatigue, hair loss, increased risk of infections (low white blood cell counts, red blood cell counts, and platelet counts), breathlessness, coughing, headache, bone or muscle pain, mouth ulcers, loss of appetite, weight loss, heart problems, liver or skin changes, low potassium levels. All of these side effects may not always occur at the same time and will vary from person to person. Serious adverse reactions include: interstitial lung disease/pneumonia, serious impairment of heart function and allergic reactions. Special care should be taken to contact your doctor in case of any serious adverse reactions.

Deruxtecan Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Deruxtecan Suppliers

Shanghai Tekanbio Pharm-Tech Co., Ltd.
Tel
021-50896099 18017206244
Fax
QQ:3268640975
Email
sales@tekanbio.com
Country
China
ProdList
102
Advantage
58
Anqing Runke Biomedical Technology Co., Ltd.
Tel
0556-5282330 18075373931
Fax
0556-5282330
Email
sales@growingchem.com
Country
China
ProdList
221
Advantage
58
ShangHai ChuanQian Chemcial Technique Centre
Tel
15869524721
Email
3525679403@qq.com
Country
China
ProdList
3616
Advantage
58
Changzhou Chenhong Biotechnology Co., Ltd.
Tel
0519-85788828 13775037613
Email
sales@chemrenpharm.com
Country
China
ProdList
3574
Advantage
58
nanjing dingda Pharmatech. co. ltd
Tel
18013843276
Email
1642441764@qq.com
Country
China
ProdList
93
Advantage
58
Levena (Suzhou) Biopharma Co., Ltd.
Tel
0512-81877925 051281877925
Email
info@levena.cn
Country
China
ProdList
48
Advantage
58
Wuhan Wiseman Bioengineering Co.,Ltd
Tel
027-59506022 13419526507
Fax
027-59506022
Email
13419526507@163.com
Country
China
ProdList
2924
Advantage
58
Wuhan Jingkangen Biomedical Technology Co., Ltd
Tel
13720134139 13720134139
Email
orders@jknbiochem.com
Country
China
ProdList
5316
Advantage
58
YJ Pharma
Tel
0513-15251351988 15251351988
Email
3686954964@qq.com
Country
China
ProdList
372
Advantage
58
Chemvon Biotechnology Co., Ltd
Tel
021-50790412
Fax
+86-21-50790419
Email
info@chemvon.com
Country
China
ProdList
371
Advantage
57
More
Less

View Lastest Price from Deruxtecan manufacturers

Henan Aochuang Chemical Co.,Ltd.
Product
Deruxtecan 1599440-13-7
Price
US $0.00-0.00/KG
Min. Order
1KG
Purity
98%
Supply Ability
1Ton
Release date
2022-10-13

1599440-13-7, DeruxtecanRelated Search:


  • Deruxtecan analog
  • Deruxtecan
  • Glycinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]glycylglycyl-L-phenylalanyl-N-[[2-[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl]amino]-2-oxoethoxy]methyl]-
  • MC-GGFG-Exetecan
  • Deruxtecan(DX-8951)
  • N-((S)-10-Benzyl-1-(((1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl)amino)-1,6,9,12,15-pentaoxo-3-oxa-5,8,11,14-tetraazahexadecan-16-yl)-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamide
  • Drug-Linker Conjugates for ADC,Inhibitor,inhibit,Deruxtecan
  • Ibandronate Impurity 32
  • N-[(S)-10-Benzyl-1-[[(1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-1,2,3,9,10,12,13,15-octahydrobenzo[de]pyrano[3’,4’:6,7]indolizino[1,2-b]quinolin-1-yl]amino]-1,6,9,12,15-pentaoxo-3-oxa-5,8,11,14-tetraazahexadecan-16-yl]-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamide
  • MC-GGFG-Exetecan Deruxtecan analog
  • N-((S)-10-Benzyl-1-(((1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl)amino)-1,6,9,12,15-pentaoxo-3-oxa-5,8,11,14-tetraazahexadecan-16-yl)-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamide
  • 1599440-13-7
  • C52H56FN9O13
  • Pharmaceutical
  • API
  • ADC